Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Agreement to Promote Development of Single-Use Biomass Sensors

By BiotechDaily International staff writers
Posted on 11 Mar 2013
Print article
A recently announced marketing and development agreement focuses on single-use biosensors that are used by the biopharmaceutical industry for obtaining in-line biomass measurements during cell cultivation and fermentation processes.

Sartorius Stedim Biothech (Aubagne, France), a leading provider of equipment and services for development, quality assurance, and production in the biopharmaceutical industry, will be cooperating with Aber Instruments (Aberystwyth, United Kingdom), a global leader in in-line biomass measurement technology. Biomass sensors are high-performance tools for modeling and optimizing biopharmaceutical development and manufacturing processes.

The agreement will give Sartorius exclusive global marketing and distribution rights to Aber's single-use sensor technology for the biopharmaceutical market. Sartorius will manufacture the biomass sensors under license, integrate these into its single-use bioreactors, and exclusively market these products in a dual-branding arrangement. New single-use sensors will be developed by both companies.

"Single-use sensors make our disposable bags even more intelligent," said Stefan Schlack, senior vice president of marketing at Sartorius Stedim Biothech. "They deliver real-time information about the progress of cell culture processes and help biopharmaceutical customers to understand their processes even better and further optimize them – a decisive competitive advantage."

Dr. John Carvell, sales and marketing director at Aber Instruments, said, "Based on Sartorius Stedim Biothech's global sales and distribution network, we can make our technology accessible to an even wider group of customers. Sartorius has in-depth expertise in single-use technology and is thoroughly versed in bioprocesses. Together with our profound knowledge of in-line biomass measurement, both companies stand to benefit from the joint development of new sensors.”

Related Links:

Sartorius Stedim Biothech
Aber Instruments




Print article

Channels

Genomics/Proteomics

view channel
Image: Follicular helper T-cells (TFH cells, shown in blue) play a crucial role in the maturation of antibody-producing B-cells (shown in green). Activated B-cells give rise germinal centers (shown in red), where mature B-cells proliferate and produce highly specific antibodies against pathogens. Top left: normal germinal center in a mouse tonsil. All others: Germinal centers fail to form when the interaction between ICOS and TBK1 is interrupted (Photo courtesy of Dr. Kok-Fai Kong, La Jolla Institute for Allergy and Immunology).

Molecular Pathway Controlling High-affinity Antibody Production Identified

A molecular pathway has been identified that controls formation of follicular helper T-cells (TFH cells) germinal centers and production of high-affinity antibodies through interaction with the inducible... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.